Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma
Lancet Microbe
.
2020 Jun;1(2):e63.
doi: 10.1016/S2666-5247(20)30037-9.
Epub 2020 Jun 8.
Authors
Torsten Tonn
1
2
,
Victor M Corman
3
4
,
Matthias Johnsen
2
,
Anja Richter
3
4
,
Roman N Rodionov
5
,
Christian Drosten
3
4
,
Stefan R Bornstein
5
6
Affiliations
1
Experimental Transfusion Medicine, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
2
Institute for Transfusion Medicine, German Red Cross Blood Donation Service North East, D-01307 Dresden, Germany.
3
Charité-Universitätsmedizin Berlin Institute of Virology, Berlin, Germany.
4
German Centre for Infection Research, Berlin, Germany.
5
Department of Medicine III, University Hospital Carl-Gustav, Dresden, Germany.
6
Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK.
PMID:
32835332
PMCID:
PMC7279746
DOI:
10.1016/S2666-5247(20)30037-9
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Viral / therapeutic use
COVID-19 Serotherapy
COVID-19* / therapy
Humans
Immunization, Passive
Immunoglobulin M
SARS-CoV-2*
Substances
Antibodies, Viral
Immunoglobulin M